These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 405166)

  • 1. Levamisole augments the cytotoxic T-cell response depending on the dose of drugs and antigen administered.
    Faanes RB; Dillon P; Choi YS
    Clin Exp Immunol; 1977 Mar; 27(3):502-6. PubMed ID: 405166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of two bisdioxopiperazines on mouse B-and T-cell function.
    Dennert G; Hatlen LE; Tucker DF
    J Natl Cancer Inst; 1975 Mar; 54(3):621-9. PubMed ID: 804564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacological and immunotherapeutic properties of levamisole (a review of the literature)].
    Sakharchuk II; Skakal'skaia LM
    Vrach Delo; 1982 Aug; (8):4-8. PubMed ID: 6983185
    [No Abstract]   [Full Text] [Related]  

  • 4. Generation of cytotoxic T lymphocytes in vitro. V. Response of normal and immune spleen cells to subcellular alloantigens.
    Engers HD; Thomas K; Cerottini JC; Brunner KT
    J Immunol; 1975 Aug; 115(2):356-60. PubMed ID: 807632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antigen density on complement-mediated lysis, T-cell-mediated killing, and antigenic modulation.
    Lesley J; Hyman R; Dennert G
    J Natl Cancer Inst; 1974 Dec; 53(6):1759-65. PubMed ID: 4140238
    [No Abstract]   [Full Text] [Related]  

  • 6. The relation between the T cells responsible for cell-mediated cytotoxic killing of mastocytoma cells and the helper-cell effect.
    Igarashi T; Okada M; Kishimoto S; Yamamura Y
    Immunology; 1975 Jan; 28(1):37-47. PubMed ID: 803916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of the administration of levamisole on the reactivity of T-lymphocytes in advanced cancer patients].
    Renoux G; Renoux M
    Nouv Presse Med; 1976 Jan; 5(2):67-70. PubMed ID: 772602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of specific and non-specific tumour immunity after azathioprine treatment of mice.
    Purves EC
    Clin Exp Immunol; 1975 Nov; 22(2):348-58. PubMed ID: 813934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined cytolytic effect of x irradiation and cell-mediated immune reactions on tumor cells in vitro.
    Song CW; Levitt SH
    Radiology; 1974 Apr; 111(1):211-2. PubMed ID: 4205812
    [No Abstract]   [Full Text] [Related]  

  • 10. Allograft cytotoxicity. Role of T lymphocytes bearing a receptor for complement.
    Arnaiz-Villena A; Jones B; Roitt IM
    Immunology; 1975 Nov; 29(5):903-8. PubMed ID: 811554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo effect of levamisole on cellular and humoral immunity in normal chickens.
    Soppi E; Lassila O; Viljanen MK; Lehtonen OP; Eskola J
    Clin Exp Immunol; 1979 Dec; 38(3):609-14. PubMed ID: 119598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulator T cells: involvement in the induction of cell-mediated cytotoxicity.
    Dennert G
    J Immunol; 1975 May; 114(5):1570-3. PubMed ID: 804519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genes coding for tumor rejection antigens: perspectives for specific immunotherapy.
    Boon T; Coulie P; Marchand M; Weynants P; Wölfel T; Brichard V
    Important Adv Oncol; 1994; ():53-69. PubMed ID: 8206495
    [No Abstract]   [Full Text] [Related]  

  • 14. Cooperation and cell-mediated cytotoxicity as functions of two subsets of T cells.
    Dennert G; Lennox ES
    J Immunol; 1974 Nov; 113(5):1553-61. PubMed ID: 4213868
    [No Abstract]   [Full Text] [Related]  

  • 15. Lectin-induced nonlethal adhesions between cytolytic T lymphocytes and antigenically unrecognizable tumor cells and nonspecific "triggering" of cytolysis.
    Parker WL; Martz E
    J Immunol; 1980 Jan; 124(1):25-35. PubMed ID: 6765968
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantitative effects of nutritional protein and calorie deficiency upon immune responses to tumors in mice.
    Jose DG; Good RA
    Cancer Res; 1973 Apr; 33(4):807-12. PubMed ID: 4633154
    [No Abstract]   [Full Text] [Related]  

  • 17. [Targets and mechanisms of levamisole-induced immunostimulation (author's transl)].
    Renoux G; Renoux M
    Nouv Presse Med; 1978 Jan; 7(3):197-201. PubMed ID: 307228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunomodulating effect of levamisole on cell-mediated immunity (author's transl)].
    Miwa H; Orita K
    Nihon Gan Chiryo Gakkai Shi; 1981 Oct; 16(6):1231-8. PubMed ID: 7037998
    [No Abstract]   [Full Text] [Related]  

  • 19. Modulation of the cytotoxic response against allogeneic tumor cells in culture by adriamycin.
    Tomazic V; Ehrke MJ; Mihich E
    Cancer Res; 1980 Aug; 40(8 Pt 1):2748-55. PubMed ID: 6248213
    [No Abstract]   [Full Text] [Related]  

  • 20. Lymphocytes T and pharmacokinetics after a single oral dose of levamisole in healthy and cancer subjects.
    Luyckx M; Cazin M; Brunet C; Cazin JC; Devulder B; Gosselin P; Adenis L; Cappelaere P; Granier AM; Demaille A
    Methods Find Exp Clin Pharmacol; 1983 Sep; 5(7):467-9. PubMed ID: 6608036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.